share_log

ITeos Therapeutics Q2 2024 GAAP EPS $(0.18) Beats $(1.04) Estimate, Pro Forma Cash And Investment Balance Of $714.4M As Of June 30, 2024 Expected To Provide Runway Through 2027

Benzinga ·  Aug 8 20:17
ITeos Therapeutics Q2 2024 GAAP EPS $(0.18) Beats $(1.04) Estimate, Pro Forma Cash And Investment Balance Of $714.4M As Of June 30, 2024 Expected To Provide Runway Through 2027
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment